๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

17 recruiting trials

for Cytomegalovirus Prophylaxis

The Use of Cytomegalovirus Cell Mediated Immunity to Optimize the Duration of Letermovir Prophylaxis in Hematopoietic Cell Transplant Recipients NCT06639854NA1 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Hematopoietic Cell Transplant, Letermovir Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy NCT04056533Phase 21 site๐Ÿ“ Santander Instituto de Investigaciรณn Marquรฉs de Valdecilla ยท Tests: CMV CTLs A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077) NCT07199465Phase 121 sites๐Ÿ“ Birmingham๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles Merck Sharp & Dohme LLC ยท Tests: Letermovir A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients NCT05711667Phase 333 sites๐Ÿ“ Birmingham๐Ÿ“ Oakland๐Ÿ“ San Francisco Children's Oncology Group ยท Tests: Biospecimen Collection, Letermovir Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients NCT06407232Phase 31 site๐Ÿ“ Madison University of Wisconsin, Madison ยท Tests: Letermovir Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients NCT06494033n/a1 site๐Ÿ“ Miami University of Miami Leflunomide to Prevent Cytomegalovirus Reactivation in Stem Cell Transplant Patients NCT07709013Phase 23 sites๐Ÿ“ Navi Mumbai๐Ÿ“ Navi Mumbai๐Ÿ“ Navi Mumbai Tata Memorial Centre ยท Tests: Leflunomide 20 mg Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study NCT07294547NA1 site๐Ÿ“ Taipei National Taiwan University Hospital ยท Tests: Valacyclovir (Valtrex), Valganciclovir (Valcyte) Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients NCT06798909Phase 38 sites๐Ÿ“ San Francisco๐Ÿ“ Miami๐Ÿ“ Atlanta University of California, San Francisco ยท Tests: Valganciclovir (Pre-emptive CMV Therapy), Valganciclovir CMV Prophylaxis Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell NCT06575374Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Letermovir Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Disease in Chinese Kidney Transplant Recipients NCT07266467Phase 41 site๐Ÿ“ Xi'an First Affiliated Hospital Xi'an Jiaotong University ยท Tests: Letermovir, Valganciclovir Breakthrough CMV Lung Transplant -Multicentre NCT04439916n/a1 site๐Ÿ“ Edmonton University of Alberta CMV Immunity Monitoring in Lung Transplant Recipients NCT05708755Phase 21 site๐Ÿ“ New York NYU Langone Health ยท Tests: Cytomegalovirus T Cell Immunity Panel (CMV-TCIP), Donor-Derived Cell-Free DNA (dd-cfDNA) Assay, Valganciclovir Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT. NCT07569653Phase 412 sites๐Ÿ“ Beijing๐Ÿ“ Shijiazhuang๐Ÿ“ Zhengzhou WeiShi ยท Tests: CMV-Specific T-cell Guided Letermovir Discontinuation, Standard Letermovir Prophylaxis Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT NCT06812598NA1 site๐Ÿ“ Suzhou The First Affiliated Hospital of Soochow University ยท Tests: Letermovir (0-24w๏ผ‰, Letermovir (0-14w๏ผ‰ Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV) NCT06958796Phase 42 sites๐Ÿ“ Boston๐Ÿ“ Dallas Camille N. Kotton, MD ยท Tests: Cytomegalovirus Immune Globulin Intravenous (Human) monthly for three months Immunoglobiulin-specific Prophylaxis of Citomegalovirus Infections in Immunocompromised Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation NCT07013370n/a1 site๐Ÿ“ Trieste Antonello Di Paolo, M.D., Ph.D. ยท Tests: Anti-CMV immunoglobulins [Megalotect (R)]
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy